Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative
lupus nephritis. Ann Rheum Dis 2012; 71: 966–973.
395 Carette S, Klippel J, Decker J, Austin H, Plotz P, Steinberg A et al. Controlled studies of
oral immunosuppressive drugs in lupus nephritis. A long-term follow-up. Ann Intern Med
1983; 99: 1–8.
396 Dinant HJ, Decker JL, Klippel JH, Balow JE, Plotz PH, Steinberg AD et al. Alternative
modes of cyclophosphamide and azathioprine therapy in lupus nephritis. Ann Intern Med
1982; : 728–736.
397 Chen W, Liu Q, Tang X, Fu P, Liu F, Liao Y et al. Outcomes of maintenance therapy with
tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical
trial. Lupus 2012; 21: 944–952.
398 Naughton MA, Battaglia E, Brien SO, Walport MJ, Botto M. Identification of thiopurine
methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic
lupus erythematosus patients taking azathioprine. Rheumatology 1999; 38: 640–644.
399 Yap DYH, Yu X, Chen X-M, Lu F, Chen N, Li X-W et al. Pilot 24 month study to
compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus
nephritis with nephrotic syndrome. Nephrology 2012; 17: 352–357.
400 Doria A, Piccoli A, Vesco P, Vaccaro E, Marson P, De Silvestro G et al. Therapy of lupus
nephritis. A two-year prospective study. Ann Med Interne (Paris) 1993; 145: 307–311.
401 Lewis E, Hunsicker L, Lan S, Rohde R, Lachin J. A controlled trial of plasmapheresis
therapy in severe lupus nephritis. N Engl J Med 1992; 326: 1373–1379.
402 Wallace DJ, Goldfinger D, Pepkowitz SH, Fichman M, Metzger a L, Schroeder JO et al.
Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for
proliferative lupus nephritis. J Clin Apher 1998; 13: 163–166.
403 Wei N, Klippel J, Huston D, Hall R, Lawley T, Balow J et al. Randomized trial of plasma
exchange in mild systemic lupus erythematosus. Lancet 1983; 1: 17–21.
404 Gaubitz M, Seidel M, Kummer S, Schotte H, Perniok a, Domschke W et al. Prospective
randomized trial of two different immunoadsorbers in severe systemic lupus
erythematosus. J Autoimmun 1998; 11: 495–501.
405 Hershko AY, Scheiman-Elazari A, Aamar S, Naparstek Y. Extracorporeal
immunoadsorption of antibodies against the VRT-101 laminin epitope in systemic lupus
erythematosus: a feasibility evaluation study. Immunol Res 2013; 56: 376–381.
406 Schiel R, Bambauer R, Latza R, Klinkmann J. Cyclosporine and therapeutic plasma
exchange in treatment of progressive autoimmune diseases. Artif Organs 1997; 21: 983–
988.
407 Soerensen H, Schneidewind-Mueller J-M, Lange D, Kashiwagi N, Franz M, Yokoyama T
et al. Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus
erythematosus. Rheumatol Int 2006; 26: 409–415.
GUÍA DE PRÁCTICA CLÍNICA SOBRE LUPUS ERITEMATOSO SISTÉMICO 465